You are here

  • Home
  • Online First
  • Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA) XXIV: Cytotoxic Therapy is an Additional Risk Factor for the Development of Symptomatic Osteonecrosis in Lupus Patients. Results of a Nested Matched Case-Control Study

Article Text

Article menu

other Versions

Download PDFPDF
Extended Report
Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA) XXIV: Cytotoxic Therapy is an Additional Risk Factor for the Development of Symptomatic Osteonecrosis in Lupus Patients. Results of a Nested Matched Case-Control Study

https://doi.org/10.1136/ard.2005.040428

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.